Operating Lease, Right-of-Use Asset of Monopar Therapeutics from 30 Sep 2021 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Monopar Therapeutics quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Sep 2021 to 30 Sep 2025.
  • Monopar Therapeutics Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $106,666.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Monopar Therapeutics Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $106,666 +$106,666 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $118,170 +$118,170 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $9,102 +$9,102 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $0 -$12,646 -100% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 $0 -$25,088 -100% 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 $0 -$37,330 -100% 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q1 2024 $0 -$49,376 -100% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $12,646 -$48,582 -79% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $25,088 -$47,801 -66% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $37,330 -$47,033 -56% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $49,376 -$4,318 -8% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $61,228 +$61,228 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 $72,889 +$72,889 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $84,363 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $53,694 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $0 31 Dec 2021 10-K 23 Mar 2023 2022 FY
Q3 2021 $0 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.